Medical Condition News

RSS

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Eli Lilly and Company and Sarah Cannon Research Institute today announced a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor. Under the agreement, SCRI will collaborate with Lilly to provide clinical development expertise and program design, as well as medical oversight and trial management. Patient enrollment for the initial Phase II clinical trial is underway.

17 Jun 2015

CGRP monoclonal antibodies show promise in treating migraine

Migraine researchers and clinicians are growing excited about a new class of drugs called Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies, which are showing promise in treating high-frequency episodic migraine and chronic migraine.

17 Jun 2015

Wilson Therapeutics supports BIG WOW event to increase awareness of Wilson's Disease

Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG WOW). The event will take place on September 19, 2015 in sixteen cities across North America to increase awareness of Wilson's Disease and raise funds for the Wilson Disease Association.

17 Jun 2015

Loyola patient celebrates 10th anniversary of heart and double-lung transplant

On March 20, Andrew Gaumer celebrated the 10th anniversary of his life-saving heart and double-lung transplant. On Mother's Day, his wife, Andrea, gave birth to their first child, a baby boy named Jude. And on June 21, Andrew will celebrate his first Father's Day - a milestone he once feared he would never see.

17 Jun 2015

New open access journal to deliver case reports on all aspects of pancreatic cancer

Case Reports in Pancreatic Cancer, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers, will deliver authoritative case reports on all aspects of pancreatic cancer diagnosis, management, treatment, and outcomes.

17 Jun 2015

Helmholtz Zentrum München scientists investigating molecular causes of COPD

At present, there is a lack of effective treatments that target the causes of chronic obstructive pulmonary disease (COPD). Scientists of the Comprehensive Pneumology Center at Helmholtz Zentrum München are therefore investigating the molecular causes of COPD in order to intervene specifically.

17 Jun 2015

Ruhr-Universität Bochum scientists develop mouse model to investigate SCA6

Scientists at the Ruhr-Universität Bochum established a mouse model for the human disease SCA6. SCA6 is characterised by movement deficits and caused by similar genetic alterations as Chorea Huntington. The mouse model will be used to investigate the disease mechanisms.

17 Jun 2015

New form of talking therapy shows promise for people suffering from chronic low back pain

New research from Royal Holloway, University of London has found that a new form of talking therapy is a credible and promising treatment for people with chronic low back pain who are also suffering from related psychological stress.

17 Jun 2015

Loyola tests new combination treatment for people living with cancer that has spread to spine

Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.

17 Jun 2015

Antibiotic treatment not better than appendectomy for uncomplicated acute appendicitis

Among patients with uncomplicated appendicitis, antibiotic treatment did not meet a prespecified level of effectiveness compared with appendectomy, although most patients who received antibiotic therapy did not require an appendectomy, and for those who did, they did not experience significant complications, according to a study in the June 16 issue of JAMA.

17 Jun 2015

New study reports more practical approach to heal the heart after a heart attack

Stem cell have been the main focus of healing therapy research because they can morph into new cells, and using a patient's own stem cells will not induce an autoimmune response. For healing after a heart attack, the ideal time to administer these therapies is when reopening the clogged blood vessel because the heart is easily accessible. While stem cells show promise for heart attack treatment, the process of harvesting and reintroducing the cells—which can take days or weeks—is too slow for this window.

17 Jun 2015

RPCI receives NCI grant to continue research program on photodynamic therapy for head and neck cancers

Roswell Park Cancer Institute has received continuation of a prestigious program project grant from the National Cancer Institute for research through the Roswell Park Photodynamic Therapy Center.

17 Jun 2015

Research finding could help develop artificial retinas for people with vision loss

Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted. But how did your eyes detect that movement? It's a question that has confounded scientists. Now, studying mice, researchers at Washington University School of Medicine in St. Louis have an answer: A neural circuit in the retina at the back of the eye carries signals that enable the eye to detect movement.

17 Jun 2015

Rapamycin drug reduces obesity, preserves lean body mass in older rats

Aging can cause many changes to the body, including obesity and a loss of lean mass. Now, a group of University of Florida Health researchers has discovered that an existing drug reduces body fat and appetite in older rats, which has intriguing implications for aging humans.

17 Jun 2015

DCRI announces new study to better understand lipid management

At a time when lipid management in the United States is undergoing transition in response to new guideline recommendations and expanding lipid-lowering therapy options, the Duke Clinical Research Institute (DCRI) today announced a new study to better understand contemporary lipid management as well as the beliefs and attitudes of patient and providers regarding cholesterol, cardiovascular risk assessment, and options for lipid treatments.

17 Jun 2015

Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma

Physicians at La Fe University and Polytechnic Hospital - Valencia presented their early clinical outcome data on the use of Esteya electronic brachytherapy for the treatment of basal cell carcinoma in a paper in the current issue of Journal of Contemporary Brachytherapy. The ongoing study showed 100 percent complete response and excellent cosmetic outcome in all lesions treated to date with Esteya.

From Elekta 17 Jun 2015

Atopix raises additional development capital to investigate OC459 for treatment of asthma

Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma.

17 Jun 2015

ABC Medical Home program achieves significant health improvement for people with depression

The Aging Brain Care Medical Home, a novel population health management program implemented in the homes of older adults achieves significant health improvement for individuals with depression and also substantial stress reduction in family caregivers of dementia patients, according to a new study by investigators from the Regenstrief Institute, Indiana University Center for Aging Research and Eskenazi Health.

17 Jun 2015

TSRI chemists invent scalable method for synthesizing brain-protecting compound

Chemists at The Scripps Research Institute have invented the first practical, scalable method for synthesizing jiadifenolide, a plant-derived molecule that may have powerful brain-protecting properties.

17 Jun 2015

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

Cancer and type 2 diabetes are two of the most significant public health burdens facing the world today, and currently available data suggests their prevalence is expected to continue to increase. Nut consumption has long been hypothesized to have a role in preventing both of these diseases, but until now evidence has been inconsistent.

17 Jun 2015

Medical Condition News

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

CGRP monoclonal antibodies show promise in treating migraine

Wilson Therapeutics supports BIG WOW event to increase awareness of Wilson's Disease

Loyola patient celebrates 10th anniversary of heart and double-lung transplant

New open access journal to deliver case reports on all aspects of pancreatic cancer

Helmholtz Zentrum München scientists investigating molecular causes of COPD

Ruhr-Universität Bochum scientists develop mouse model to investigate SCA6

New form of talking therapy shows promise for people suffering from chronic low back pain

Loyola tests new combination treatment for people living with cancer that has spread to spine

Antibiotic treatment not better than appendectomy for uncomplicated acute appendicitis

New study reports more practical approach to heal the heart after a heart attack

RPCI receives NCI grant to continue research program on photodynamic therapy for head and neck cancers

Research finding could help develop artificial retinas for people with vision loss

Rapamycin drug reduces obesity, preserves lean body mass in older rats

DCRI announces new study to better understand lipid management

Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma

Atopix raises additional development capital to investigate OC459 for treatment of asthma

ABC Medical Home program achieves significant health improvement for people with depression

TSRI chemists invent scalable method for synthesizing brain-protecting compound

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News